Last reviewed · How we verify
NCT06151509
90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment
NA trial testing Alpha-Agonist in Adverse Effect in 80 participants. Status unknown.
31 March 2025
Quick facts
| Lead sponsor | General Hospital of Ningxia Medical University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 January 2025 |
| Primary completion | 31 March 2025 |
| Estimated completion | 31 March 2025 |
Drugs / interventions tested
- Alpha-Agonist — full drug profile →
- α-adrenergic receptor agonist — full drug profile →
Conditions studied
- Adverse Effect — all drugs for Adverse Effect →
Sponsor
General Hospital of Ningxia Medical University
Who can join
Adults 18 to 45, female only, with Adverse Effect. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to investigate the 90% effective dose of norepinephrine infusions for preventing postspinal anesthesia hypotension under intensive and standard treatment during cesarean section
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06151509
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Alpha-Agonist
Trials testing the same drug.
- NCT06151470 — 90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients · NA · unknown
- NCT06151522 — 90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment · NA · unknown
- NCT06151457 — 90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients · NA · unknown
- NCT06151496 — Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension on Maternal Hemodynamics · NA · unknown
- NCT06151444 — Intensive Versus Standard Treatment for Hypotension on Maternal Hemodynamics in Preeclamptic Patients · NA · unknown
Other recruiting trials for Adverse Effect
Currently open trials in the same condition.
- NCT06570629 — Addressing Unintentional Leakage When Using Nasal CPAP - Study B · NA · recruiting
- NCT06570616 — Addressing Unintentional Leakage When Using Nasal CPAP - Study A · NA · recruiting
- NCT06467045 — Frequency of Adverse Events in Pediatric Patients Receiving Sedation for Magnetic Resonance Imaging · recruiting
Other General Hospital of Ningxia Medical University trials
Trials by the same sponsor.
- NCT07496086 — External Oblique Intercostal Block Versus Transversus Abdominis Plane Combined With Rectus Sheath Block on Postoperative · NA · recruiting
- NCT07396545 — External Oblique Intercostal Block Versus Erector Spinae Plane Block on Postoperative Pain in Laparoscopic Radical Gastr · NA · recruiting
- NCT07366853 — Feasibility and Safety of Sciatic Nerve Paraneural Sheath Block Using a Mid-Femoral Lateral Approach · NA · not yet recruiting
- NCT07239531 — The Application of Intermittent Training in Clinical Skills Simulation Training · NA · not yet recruiting
- NCT07248683 — Application of Intermittent Training in Radial Artery Puncture and Catheterization Skills Under Ultrasound-Guided Line G · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06151509 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by General Hospital of Ningxia Medical University
- Last refreshed: 30 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06151509.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing